Gregory Carter v. HHS - Tdap, Miller Fisher variant of Guillain-Barré syndrome (2021)
Case summary [AI summaries can sometimes make mistakes]
Gregory Carter filed a petition on June 15, 2021, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he suffered from the Miller Fisher variant of Guillain-Barré syndrome as a result of a tetanus diphtheria and acellular pertussis (Tdap) vaccination he received on February 27, 2018.
The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Mr. Carter's alleged injury or any other condition.
Despite maintaining their respective positions, both parties agreed to settle the case through a joint stipulation filed on June 15, 2021. Special Master Katherine E.
Oler reviewed the file and found the stipulation to be reasonable, adopting it as her decision. The stipulation awarded Mr.
Carter a lump sum of $105,000.00, payable by check, as compensation for all damages available under the program. The decision directed the Clerk of the Court to enter judgment accordingly, unless a motion for review was filed.
Theory of causation
Petitioner Gregory Carter alleged that a Tdap vaccination received on February 27, 2018, caused his Miller Fisher variant of Guillain-Barré syndrome. Respondent denied causation. The parties reached a stipulation to settle the case, with Special Master Katherine E. Oler adopting the stipulation as her decision. The stipulation awarded Petitioner a lump sum of $105,000.00 for all damages. The public decision does not detail the specific theory of causation, medical experts, or clinical findings.
Source PDFs
USCOURTS-cofc-1_20-vv-00767